RT Journal Article
SR Electronic
T1 Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.10.21267840
DO 10.1101/2022.01.10.21267840
A1 Constantinos Constantinides
A1 Laura KM Han
A1 Clara Alloza
A1 Linda Antonucci
A1 Celso Arango
A1 Rosa Ayesa-Arriola
A1 Nerisa Banaj
A1 Alessandro Bertolino
A1 Stefan Borgwardt
A1 Jason Bruggemann
A1 Juan Bustillo
A1 Oleg Bykhovski
A1 Vaughan Carr
A1 Stanley Catts
A1 Young-Chul Chung
A1 Benedicto Crespo-Facorro
A1 Covadonga M Díaz-Caneja
A1 Gary Donohoe
A1 Stefan Du Plessis
A1 Jesse Edmond
A1 Stefan Ehrlich
A1 Robin Emsley
A1 Lisa T Eyler
A1 Paola Fuentes-Claramonte
A1 Foivos Georgiadis
A1 Melissa Green
A1 Amalia Guerrero-Pedraza
A1 Minji Ha
A1 Tim Hahn
A1 Frans A Henskens
A1 Laurena Holleran
A1 Stephanie Homan
A1 Philipp Homan
A1 Neda Jahanshad
A1 Joost Janssen
A1 Ellen Ji
A1 Stefan Kaiser
A1 Vasily Kaleda
A1 Minah Kim
A1 Woo-Sung Kim
A1 Matthias Kirschner
A1 Peter Kochunov
A1 Yoo Bin Kwak
A1 Jun Soo Kwon
A1 Irina Lebedeva
A1 Jingyu Liu
A1 Patricia Mitchie
A1 Stijn Michielse
A1 David Mothersill
A1 Bryan Mowry
A1 Víctor Ortiz-García de la Foz
A1 Christos Pantelis
A1 Giulio Pergola
A1 Fabrizio Piras
A1 Edith Pomarol-Clotet
A1 Adrian Preda
A1 Yann Quidé
A1 Paul E Rasser
A1 Kelly Rootes-Murdy
A1 Raymond Salvador
A1 Marina Sangiuliano
A1 Salvador Sarró
A1 Ulrich Schall
A1 André Schmidt
A1 Rodney J Scott
A1 Pierluigi Selvaggi
A1 Kang Sim
A1 Antonin Skoch
A1 Gianfranco Spalletta
A1 Filip Spaniel
A1 Sophia I. Thomopoulos
A1 David Tomecek
A1 Alexander S Tomyshev
A1 Diana Tordesillas-Gutiérrez
A1 Therese van Amelsvoort
A1 Javier Vázquez-Bourgon
A1 Daniela Vecchio
A1 Aristotle Voineskos
A1 Cynthia S Weickert
A1 Thomas Weickert
A1 Paul M Thompson
A1 Lianne Schmaal
A1 Theo GM van Erp
A1 Jessica Turner
A1 James H Cole
A1 Danai Dima
A1 Esther Walton
YR 2022
UL http://medrxiv.org/content/early/2022/01/11/2022.01.10.21267840.abstract
AB Schizophrenia (SZ) is associated with an increased risk of life-long cognitive impairments, age-related chronic disease, and premature mortality. We investigated evidence for advanced brain ageing in adult SZ patients, and whether this was associated with clinical characteristics in a prospective meta-analytic study conducted by the ENIGMA Schizophrenia Working Group. The study included data from 26 cohorts worldwide, with a total of 2803 SZ patients (mean age 34.2 years; range 18-72 years; 67% male) and 2598 healthy controls (mean age 33.8 years, range 18-73 years, 55% male). Brain-predicted age was individually estimated using a model trained on independent data based on 68 measures of cortical thickness and surface area, 7 subcortical volumes, lateral ventricular volumes and total intracranial volume, all derived from T1-weighted brain magnetic resonance imaging (MRI) scans. Deviations from a healthy brain ageing trajectory were assessed by the difference between brain-predicted age and chronological age (brain-predicted age difference [brain-PAD]). On average, SZ patients showed a higher brain-PAD of +3.64 years (95% CI: 3.01, 4.26; I2 = 55.28%) compared to controls, after adjusting for age and sex (Cohen’s d = 0.50). Among SZ patients, brain-PAD was not associated with specific clinical characteristics (age of onset, duration of illness, symptom severity, or antipsychotic use and dose). This large-scale collaborative study suggests advanced structural brain ageing in SZ. Longitudinal studies of SZ and a range of mental and somatic health outcomes will help to further evaluate the clinical implications of increased brain-PAD and its ability to be influenced by interventions.Competing Interest StatementDr. Arango has been a consultant to or has received honoraria or grants from Acadia, Angelini, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda. Dr. Jahanshad and Dr. Thompson received a research grant from Biogen, Inc. (Boston, USA) for research unrelated to this manuscript. Dr. Kaiser received royalties for cognitive test and training software from Schuhfried. The remaining authors report no biomedical financial interests or potential conflicts of interest.Funding StatementThe ENIGMA Schizophrenia Working Group acknowledges the National Institute of Health (NIH) Big Data to Knowledge (BD2K) award for foundational support and consortium development (Grant No. U54 EB020403 to PMT). For a complete list of ENIGMA-related grant support please see here: http://enigma.ini.usc.edu/about-2/funding/. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CC was supported by grant MR/N0137941/1 for the GW4 BIOMED Doctoral Training Partnership awarded to the Universities of Bath, Bristol, Cardiff and Exeter from the Medical Research Council (MRC)/UKRI. JC was supported by a UK Research & Innovation (UKRI) Innovation Fellowship (MR/R024790/2). TH was funded by the German Research Foundation (DFG grants HA7070/2-2, HA7070/3, HA7070/4 to TH). NJ and LS were supported by NIH grant R01 MH117601. NJ was also supported by NIH grants R01AG059874, R01MH11760. LS was also supported by an NHMRC Career Development Fellowship (1140764) and a University of Melbourne Dame Kate Campbell fellowship. PMT was supported in part by NIH grant R01 MH116147. EW was supported by the European Union Horizon 2020 research and innovation programme (EarlyCause, grant number 848158). Acknowledgements for the various participating data contributors follow - ASRB: the Australian Schizophrenia Research Bank (ASRB) was supported by the National Health and Medical Research Council of Australia (NHMRC) (Enabling Grant, ID 386500), the Pratt Foundation, Ramsay Health Care, the Viertel Charitable Foundation and the Schizophrenia Research Institute. Chief Investigators for ASRB were Carr, V., Schall, U., Scott, R., Jablensky, A., Mowry, B., Michie, P., Catts, S., Henskens, F., Pantelis, C. We thank Loughland, C., the ASRB Manager, and acknowledge the help of Jason Bridge for ASRB database queries. CP was also supported by a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellowship (1105825), an NHMRC L3 Investigator Grant (1196508). CSW was funded by the NSW Ministry of Health, Office of Health and Medical Research and a recipient of a National Health and Medical Research Council (Australia) Principal Research Fellowship (PRF) (#1117079). CAMH: the datasets were generated and shared with support from the CAMH Foundation and the Canadian Institutes of Health Research. CASSI: this study was supported by NHMRC grant 568807 (awarded to CSW and TW). CSW was funded by the NSW Ministry of Health, Office of Health and Medical Research and a recipient of a National Health and Medical Research Council (Australia) Principal Research Fellowship (PRF) (#1117079). COBRE: the study and investigators were supported by NIH grants R01EB006841 &P20GM103472, as well as NSF grant 1539067. JT (senior author) was supported by NIH grant R01MH121246. EONCKS: all processing of contributed neuroimaging data was conducted on the Centre for High Performance Computing, Cape Town, South Africa. ESO: the study and investigators (AC, FS, DT) was funded by the Ministry of Health, Czech Republic - Conceptual Development of Research Organization (Institute for Clinical and Experimental Medicine - IKEM, IN 00023001), and Ministry of Health of the Czech Republic, grant nr. NU20-04-00393. FBIRN: the study was supported by the National Center for Research Resources at the National Institutes of Health (NIH 1 U24 RR021992 (Function Biomedical Informatics Research Network) and NIH 1 U24 RR025736-01 (Biomedical Informatics Research Network Coordinating Center; http://www.birncommunity.org). FBIRN data was processed by the UCI High Performance Computing cluster supported by Joseph Farran, Harry Mangalam, and Adam Brenner and the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR000153. JT (senior author) was also supported by NIH grant R01MH121246. FIDMAG: this was supported by the CIBERSAM and the Catalonian Government, Generalitat de Catalunya (2017-SGR-1271 to EP-C from AGAUR). PFC was supported by a Sara Borrell contract (CD19/00149), funded by Instituto de Salud Carlos III, co-funded by the European Union (European Regional Development Fund/European Social Fund [ERDF/ESF], Investing in your future). FSLRome: the IRCCS Santa Lucia Foundation of Rome study (FSLRome) was partially supported by the Italian Ministry of Health (RC12-13-14-15A Grant) and by the European Commission ERA-Net NEURON joint transnational calI 2010 (European Research Projects on Mental Disorders: NEUCONNECT). GROUP: This work was supported by the Geestkracht program of the Dutch Health Research Council (ZON-MW, grant number: 10-000-1002), and the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). Huilong: this study was funded by the National Natural Science Foundation of China (81761128021;31671145;81401115;81401133), Beijing Municipal Science & Technology Commission grant (Z141107002514016) and Beijing Natural Science Foundation (7162087, Beijing Municipal Administration of Hospitals Clinical medicine Development of special funding (XMLX201609; zylx201409). IGP: this study was supported by National Health and Medical Research Council (NHMRC) Project Grant APP630471, APP1051673, APP1081603 (awarded to MG). IMH: this study was supported by the National Healthcare Group, Singapore (SIG/05004; SIG/05028) and the Singapore Bioimaging Consortium (RP C009/06) research grants (awarded to KS). iRELATE: this study was supported by grants to GD from the European Research Council (ERC-2015-STG-677467) and Science Foundation Ireland (SFI-16/ERCS/3787). Madrid: this research was supported by the Spanish Ministry of Science and Innovation; Instituto de Salud Carlos III (grants SAM16PE07CP1 and PI16/02012 awarded to CAra; PI17/01249 awarded JJ; and PI17/00481, PI19/00024 and PI20/00721 awarded to CMD-C), co-financed by ERDF Funds from the European Commission, A way of making Europe, CIBERSAM; Madrid Regional Government (B2017/BMD-3740 AGES-CM-2 awarded to CAra), European Union Structural Funds; European Union Seventh Framework Program under grant agreements FP7-4-HEALTH-2009-2.2.1-2-241909 (Project EU-GEI), FP7- HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN) and FP7- HEALTH-2013-2.2.1-2-602478 (Project METSY) awarded to Cara; and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement No 115916, Project PRISM, and grant agreement No 777394, Project AIMS-2-TRIALS awarded to CAra), Fundación Familia Alonso and Fundación Alicia Koplowitz. MCIC: the study was supported by the National Institutes of Health (NIH/NCRR P41RR14075 and R01EB005846 (to Vince D. Calhoun)), the Department of Energy (DE-FG02- 99ER62764), the Mind Research Network, the Morphometry BIRN (1U24, RR021382A), the Function BIRN (U24RR021992-01, NIH.NCRR MO1 RR025758-01, NIMH 1RC1MH089257 to Vince D. Calhoun). MPRC: support was received from NIH grants R01MH123163, R01EB015611, R01NS114628 (awarded to PK). PAFIP: this study has been funded by Instituto de Salud Carlos III through the project PI17/01056 (co-funded by European Regional Development Fund/European Social Fund, A way to make Europe/Investing in your future). RSCZ: data collection was supported by RFBR 15-06-05758 grant. SCORE: this study was supported in part by grant 3232BO_119382 from the Swiss National Science Foundation. We thank the FePsy (Frueherkennung von Psychosen; early detection of psychosis) Study Group from the University of Basel, Department of Psychiatry, Switzerland, for the recruitment of the study participants. The FePsy study was supported in part by grant No. SNF 3200-057216/1, ext./2, ext./3. SNUH: this research was supported by the Basic Science Research Program and the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science & ICT (Grant no. 2019R1C1C1002457 and 2020M3E5D9079910 (awarded to MK and JSK). UNIBA: this study was supported by grant funding from the Italian Ministry of Health (PE-2011-02347951). PS was supported by a PhD studentship jointly funded by the NIHR-BRC at SLaM and the Department of Neuroimaging, King′s College London. Zurich: this study was supported by the Swiss National Science Foundation (Grant No. 105314_140351 and 10001CL_169783 to SK). MK acknowledges funding from the Swiss National Science Foundation (P2SKP3_178175).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Bath Psychology Research Ethics Committee (PREC) has approved this study (REF NBR: 21-016). All participating cohorts obtained approval from local institutional review boards and ethics committees, and all study participants provided written informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.